PNU-22394

From WikiMD's WELLNESSPEDIA

PNU-22394 is a chemical compound that belongs to the class of benzodiazepine derivatives. It is a potent and selective agonist at the GABAA receptor, a type of neurotransmitter receptor in the brain. PNU-22394 has been studied for its potential use in the treatment of anxiety disorders, insomnia, and other conditions related to GABAergic dysfunction.

Chemistry[edit]

PNU-22394 is a benzodiazepine derivative, which means it is structurally related to the benzodiazepine class of drugs, which includes medications such as diazepam and alprazolam. However, PNU-22394 has a unique chemical structure that distinguishes it from other benzodiazepines.

Pharmacology[edit]

PNU-22394 acts as an agonist at the GABAA receptor, which means it enhances the activity of the neurotransmitter GABA. GABA is the primary inhibitory neurotransmitter in the brain, and its activation leads to a decrease in neuronal excitability. This action is thought to underlie the potential therapeutic effects of PNU-22394 in conditions such as anxiety and insomnia.

Clinical Potential[edit]

PNU-22394 has been studied for its potential use in the treatment of various conditions related to GABAergic dysfunction. These include anxiety disorders, insomnia, and possibly other conditions such as epilepsy and neuropathic pain. However, as of now, PNU-22394 is not approved for use in any country and is only used in research settings.

See Also[edit]

This article is a stub related to chemistry. You can help WikiMD by expanding it!


This article is a stub related to pharmacology. You can help WikiMD by expanding it!


  • PNU-22394.svg
    PNU-22394.svg
  • PNU-22394-3D-balls.png
    PNU-22394-3D-balls.png

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=PNU-22394&oldid=6307129"